UK authorizes new Pfizer vaccine targeting Omicron

Pandemic – In mid-August, the UK became the first country to allow a similar vaccine developed by Moderna Lab that also targets Omicron.

After us, it is the turn of our neighbors across the channel. regulator British of the property announced on Saturday that it has approved a new generation of Serum against the COVID-19 From Pfizer/BioNTech targeting the Omicron variant.

This version of the vaccine consists of what’s called a “bivalent” booster dose, targeting half of the original strain of the virus and half of the mutated strain. Omicron (BA.1), the MHRA said in a statement. “The booster doses for adults have been approved by the MHRA which has concluded that they meet the UK regulator’s safety, quality and efficacy standards,” the Medicines Agency, which determines the vaccine’s license for adults, for people aged 12 and over, noted.

New booster potion

In mid-August, the UK became the first country to authorize a similar laboratory-developed vaccine Moderna As well as targeting Omicron, the most common type in Europe. This announcement comes as the country prepares to provide a dose of remind Covid vaccine for millions of Britons in England and Scotlandespecially those over 50, with priority given to people living in nursing homes.

“I am happy to announce that we now have a second approved vaccine to prevent the disease (…) Read more in 20 minutes

Read also:
Covid-19 in France: A possible eighth wave looms with a slow decline
COVID-19: China confines a city with a population of more than 20 million people
Covid-19: ‘Slight rebound’ in performances before the start of the school year
Covid-19: No, the new Omicron sub-substitute is not called a ‘Centaur’
Argentina: Three people died of pneumonia of “unknown source”

See also  Sports | Wimbledon: Djokovic will find Kyrgios for a "fireworks" final

Leave a Reply

Your email address will not be published.